WEANING FROM TRACHEOSTOMY

NCT ID: NCT05271786

Last Updated: 2025-09-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

192 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-01

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tracheostomy is a very common surgical procedure performed in critically ill patients on invasive mechanical ventilation, and usually performed in difficult-to-wean patients and whn prolonged mechanical ventilation is required.

Weaning from the tracheostomy cannula (i.e. decannulation) represents one of the crucial steps in the post-acute respiratory management of these patients. Tracheostomy literature mainly focuses on the timing and technique of this procedure, but there is a lack of studies about decannulation and, currently, our knowledge is primarily based on expert opinion. The COVID-19 pandemic, due to the rapid increase in the number of patients exposed to prolonged mechanical ventilation, has stressed the need for objective parameters and shared standardized protocols to perform weaning from tracheostomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will have two co-primary objectives:

1. To review and compare the standard operating procedures adopted for decannulation at a multicenter level.
2. To retrospectively validate a clinical score for weaning from trachesotomy (Quantitative-Semi Quantitative - QSQ) Secondary objectives will be: 1) to assess the presence of predictors of decannulation failure; 2) to investigate if timing of decannulation can influence the result of the tracheostomy weaning process, and 3) to possibly derive a novel clinical score and a shared protocol for decannulation.

The investigators will retrospectively collect data from patients who underwent a tracheostomy procedure and decannulation during their hospital stay since January 2017 until November 2021.

A digital dataset will be shared with the participating centers. The following variables will be collected: age, gender, comorbidities, reason and date of tracheostomy, technique used, type of cannula, variables associated with the weaning process (timing and type of caliber reduction, tube capping, assessment of airway patency by means of fiberoptic bronchoscopy, effectiveness of cough and swallowing, type and timing of change in respiratory support), level of consciousness, vital signs, arterial blood gas analysis and blood tests before and after decannulation, failure of decannulation and related complications. The dataset will be also designed to retrospectively validate the QsQ score, which is based on two main criteria (or quantitative parameters) and eight minor criteria (or semi-quantitative parameters).

Inclusion criteria

1. Patients \>18 years old
2. Percutaneous tracheostomy performed for any reason
3. At least one decannulation attempt during the hospitalization period. Exclusion criteria

1\. Patients with surgical/permanent tracheostomy (e.g. neuromuscular disorders needing long-term invasive mechanical ventilation) 2. Patients that underwent elective tracheostomy due to neck masses or tumors, in view of a surgical approach 3. Patients tracheostomized more than once

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tracheostomy Weaning Tracheostomy Decannulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tracheostomized patients

Patients who underwent percutaneous tracheostomy performed for any reason

Decannulation

Intervention Type OTHER

retrospective evaluation of decannulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Decannulation

retrospective evaluation of decannulation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients \>18 years old
2. Percutaneous tracheostomy
3. At least one decannulation attempt

Exclusion Criteria

1. Surgical/permanent tracheostomy
2. Elective tracheostomy due to neck masses or tumors, in view of a surgical approach
3. Patients tracheostomized more than once
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dejan Radovanovic

UNKNOWN

Sponsor Role collaborator

Marina Gatti

UNKNOWN

Sponsor Role collaborator

Michele Mondoni

UNKNOWN

Sponsor Role collaborator

Stefano Centanni

UNKNOWN

Sponsor Role collaborator

Frascesco Blasi

UNKNOWN

Sponsor Role collaborator

Andrea Gramegna

UNKNOWN

Sponsor Role collaborator

Fabiano Di Marco

UNKNOWN

Sponsor Role collaborator

Stefano Aliberti

UNKNOWN

Sponsor Role collaborator

Humanitas Research Hospital IRCCS, Rozzano-Milan

OTHER

Sponsor Role collaborator

Ca' Granda Policlinico Milano

UNKNOWN

Sponsor Role collaborator

ASST Santi Paolo e Carlo

OTHER

Sponsor Role collaborator

Ospedale Luigi Sacco Milano

UNKNOWN

Sponsor Role collaborator

Papa Giovanni XXIII Bergamo

UNKNOWN

Sponsor Role collaborator

University of Milan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pierachille Santus, MD, PhD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

L. Sacco Hospital

Milan, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OR022022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.